3 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Yasmin Hurd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cannabidiol in the Treatment of Opioid Use Disorder Placebo, Cannabidiol (CBD) 200mg, Cannabidiol (CBD) 400mg - Opioid Use Disorder | Phase 2 | Completed | Yasmin Hurd | 76 | 2023-10-04 | 2026-06-18 |
| Investigation of the Pharmacokinetic Profile of CBD Cannabidiol 200mg, Epidiolex, Cannabidiol 400mg - Opioid Use Disorder | Phase 1 | Completed | Yasmin Hurd | 60 | 2022-05-18 | 2025-02-14 |
| Neuroimaging and CBD for Opioid Use Disorder Cannabidiol (CBD), Placebo - Heroin Abuse, Opioid Use Disorder | Phase 2 | Completed | Yasmin Hurd | 66 | 2020-11-12 | 2025-10-27 |
Opioid-Related Disorders (3) · Heroin Dependence (1) · Substance-Related Disorders (1)
Cannabidiol (3)
United States (3)